Pierluigi Zinzani

167PUBLICATIONS
707CO-AUTHORS
AllergyPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (167)

|Aug 11, 2026
Development and Validation of the Idiopathic Multicentric Castleman Disease Symptom Burden Scale (ISBUS): Protocol for an International Multistage Mixed Methods Study.

|Jul 24, 2026
Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

|Jul 16, 2026
First-line ibrutinib plus venetoclax for non-blastoid mantle cell lymphoma in patients ≥65 years or with TP53 mutations.

|Jul 10, 2026
Short BRAF+MEK coinhibition, alone and combined with anti-CD20 immunotherapy, in relapsed or refractory hairy cell leukemia: An investigator-sponsored multi-center phase 2 clinical trial.

|Jun 08, 2026
Occult hepatitis B virus infection status is not associated with impaired efficacy of anti-CD19 CAR-T-cell therapy for lymphoma and shows a distinct immune toxicity profile: Results from the CART-SIE study.

|May 22, 2026
Lymphoproliferation in inborn errors of immunity: From challenging diagnosis to histologic revision.

Pageof 28

Frequent Collaborators

15 joint publications

Alessandro Broccoli

11 joint publications

Lisa Argnani

11 joint publications

Paolo Corradini

9 joint publications

Francesca Bonifazi